Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 356

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Spatial predictors of immunotherapy response in triple-negative breast cancer

Open access
Wang, Xiao Qian, Danenberg, Esther, Huang, Chiun-Sheng, Egle, Daniel, Callari, Maurizio, Bermejo, Begoña, Dugo, Matteo, Zamagni, Claudio, Thill, Marc, Anton, Anton, Zambelli, Stefania, Russo, Stefania, Ciruelos, Eva Maria, Greil, Richard, Győrffy, Balázs, Semiglazov, Vladimir, Colleoni, Marco, Kelly, Catherine M., Mariani, Gabriella, Del Mastro, Lucia, Biasi, Olivia, Seitz, Robert S., Valagussa, Pinuccia, Viale, Giuseppe, Gianni, Luca, Bianchini, Giampaolo, Ali, H. Raza·2023·Nature

Abstract

Immune checkpoint blockade (ICB) benefits some patients with triple-negative breast cancer, but what distinguishes responders from non-responders is unclear 1. Because ICB targets cell–cell interactions 2, we investigated the impact of multicellular spatial organization on response, and explored how ICB remodels the tumour microenvironment. We show that cell phenotype, activation state and spatial location are intimately linked, influence ICB effect and differ in sensitive versus resistant tumours early on-treatment. We used imaging mass cytometry 3 to profile the in situ expression of 43 proteins in tumours from patients in a randomized trial of neoadjuvant ICB, sampled at three timepoints (baseline, n = 243; early on-treatment, n = 207; post-treatment, n = 210). Multivariate modelling showed that the fractions of proliferating CD8+TCF1+T cells and MHCII+ cancer cells were dominant predictors of response, followed by cancer–immune interactions with B cells and granzyme B+ T cells. On-treatment, responsive tumours contained abundant granzyme B+ T cells, whereas resistant tumours were characterized by CD15+ cancer cells. Response was best predicted by combining tissue features before and on-treatment, pointing to a role for early biopsies in guiding adaptive therapy. Our findings show that multicellular spatial organization is a major determinant of ICB effect and suggest that its systematic enumeration in situ could help realize precision immuno-oncology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06498-3

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 356

Metadata

Authors
Wang, X. Q., Danenberg, E., Huang, C.-S., Egle, D., Callari, M., Bermejo, B., Dugo, M., Zamagni, C., Thill, M., Anton, A., Zambelli, S., Russo, S., Ciruelos, E. M., Greil, R., Győrffy, B., Semiglazov, V., Colleoni, M., Kelly, C. M., Mariani, G., Del Mastro, L., Biasi, O., Seitz, R. S., Valagussa, P., Viale, G., Gianni, L., Bianchini, G., & Ali, H. R.
Venue
Nature
Published
2023-09-06
Volume
621
Issue
7980
Pages
868-876
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4386493325
Cited by
356
References
47
FWCI
36.86
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spatial predictors of immunotherapy response in triple-negative breast cancer. https://app.cochat.ai/papers/10.1038/s41586-023-06498-3
The paper
Wang, X. Q., Danenberg, E., Huang, C.-S., Egle, D., Callari, M., Bermejo, B., Dugo, M., Zamagni, C., Thill, M., Anton, A., Zambelli, S., Russo, S., Ciruelos, E. M., Greil, R., Győrffy, B., Semiglazov, V., Colleoni, M., Kelly, C. M., Mariani, G., . . . Ali, H. R. (2023). Spatial predictors of immunotherapy response in triple-negative breast cancer. Nature. https://doi.org/10.1038/s41586-023-06498-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.